Literature DB >> 33465022

A scoping review on the effect of cannabis on pain intensity in people with spinal cord injury.

Pavithra A Thomas1, Gregory T Carter2, Charles H Bombardier1.   

Abstract

CONTEXT: This scoping review examines the current research on the effect of cannabis upon pain intensity in spinal cord injury (SCI) pain. Chronic pain is a significant secondary condition following SCI, and traditional treatments (e.g. opioids, NSAIDs) are often criticized for providing inadequate relief. As a result, there is increasing interest in and use of cannabis and cannabinoid-based medications as an alternative means of pain control.
OBJECTIVE: The purpose of this review was to examine the scientific evidence on the effect of cannabis/cannabinoids upon pain intensity in SCI by mapping the current literature.
METHODS: Two hundred and fifty-two studies were identified by searching electronic databases for articles published through February 2020. In addition, reviewers scanned the reference lists of identified articles and examined clinicaltrials.gov for unpublished data in this area. Title, abstract, and full-text reviews were completed by two independent reviewers. Data extraction was performed by a single reviewer and verified by a second reviewer.
RESULTS: Six articles covering five treatment studies were included. Studies yielded mixed findings likely due to large variability in methodology, including lack of standardized dosing paradigms, modes of use, and duration of trial.
CONCLUSIONS: The current quality and level of evidence is insufficient to draw reliable conclusions of the efficacy of cannabis upon SCI-related pain itensity. We identify specific limitations of past studies and present guidelines for future research.Trial registration: ClinicalTrials.gov identifier: Nct01606202..

Entities:  

Keywords:  Cannabis; Chronic pain; Medical marijuana; Neuropathic pain; Spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 33465022      PMCID: PMC9542582          DOI: 10.1080/10790268.2020.1865709

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   2.040


  57 in total

Review 1.  Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design.

Authors:  D Lammertse; M H Tuszynski; J D Steeves; A Curt; J W Fawcett; C Rask; J F Ditunno; M G Fehlings; J D Guest; P H Ellaway; N Kleitman; A R Blight; B H Dobkin; R Grossman; H Katoh; A Privat; M Kalichman
Journal:  Spinal Cord       Date:  2006-12-19       Impact factor: 2.772

Review 2.  Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics.

Authors:  M H Tuszynski; J D Steeves; J W Fawcett; D Lammertse; M Kalichman; C Rask; A Curt; J F Ditunno; M G Fehlings; J D Guest; P H Ellaway; N Kleitman; P F Bartlett; A R Blight; V Dietz; B H Dobkin; R Grossman; A Privat
Journal:  Spinal Cord       Date:  2006-12-19       Impact factor: 2.772

3.  The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.

Authors:  U Hagenbach; S Luz; N Ghafoor; J M Berger; F Grotenhermen; R Brenneisen; M Mäder
Journal:  Spinal Cord       Date:  2006-10-17       Impact factor: 2.772

4.  Using cannabis for pain management after spinal cord injury: a qualitative study.

Authors:  John A Bourke; Victoria J Catherwood; Joanne L Nunnerley; Rachelle A Martin; William M M Levack; Bronwyn L Thompson; Richard H Acland
Journal:  Spinal Cord Ser Cases       Date:  2019-10-08

Review 5.  Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.

Authors:  Eric P Baron
Journal:  Headache       Date:  2018-07       Impact factor: 5.887

6.  Chronic spinal cord injury pain: pharmacological and non-pharmacological treatments and treatment effectiveness.

Authors:  Matagne Heutink; Marcel W M Post; Marieke M Wollaars; Floris W A van Asbeck
Journal:  Disabil Rehabil       Date:  2010-08-09       Impact factor: 3.033

Review 7.  Targeting the cannabinoid system for pain relief?

Authors:  Lih-Chu Chiou; Sherry Shu-Jung Hu; Yu-Cheng Ho
Journal:  Acta Anaesthesiol Taiwan       Date:  2013-12-25

8.  Management of Neuropathic Pain Associated with Spinal Cord Injury.

Authors:  Ellen M Hagen; Tiina Rekand
Journal:  Pain Ther       Date:  2015-03-06

9.  Getting high on the endocannabinoid system.

Authors:  Bradley E Alger
Journal:  Cerebrum       Date:  2013-11-01

Review 10.  Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.

Authors:  Shenglong Zou; Ujendra Kumar
Journal:  Int J Mol Sci       Date:  2018-03-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.